IP Library Patent Application 14807747
Patent Application
App. No. 14/807,747

Inducible Expression System Transcription Modulators Comprising A Distributed Protein Transduction Domain And Methods For Using The Same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/807,747
Abstract

Aspects of the invention include inducible expression systems in which a transcription modulator having a distributed protein transduction domain is employed. Aspects of the invention further include methods of using the systems to induce expression of a coding sequence, as well as kits that find use in practicing methods of the invention. The systems, components thereof, methods and kits find use in a variety of different applications.

Claims (42)

1 . An inducible expression system comprising:

(a) a host cell comprising an expression cassette comprising:

(i) a transcription modulator responsive element;

(ii) a promoter; and

(iii) a coding sequence; and

(b) a transcription modulator comprising:

(i) a transcription modulator domain that binds to the transcription modulator responsive element;

(ii) an expression modulatory domain operably linked to the transcription modulator domain; and

(iii) a distributed protein transduction domain.

2 . The expression system according to claim 1 , wherein the transcription modulator responsive element is a Tet responsive element.

3 . The expression system according to claim 1 , wherein the transcription modulator domain is a Tet transcription modulator domain.

4 . The expression system according to claim 3 , wherein the Tet transcription modulator binds to the transcription modulator responsive element in the absence of an expression mediator.

5 . The expression system according to claim 3 , wherein the Tet transcription modulator binds to the transcription modulator responsive element in the presence of an expression mediator.

6 . The expression system according to claim 1 , wherein the system further includes an expression mediator.

7 . The expression system according to claim 6 , wherein the expression mediator is selected from the group consisting of tetracycline and doxycycline.

8 . The expression system according to claim 1 , wherein the distributed protein transduction domain comprises a basic patch made up 3 or more non-sequential basic amino acid residues.

9 . The expression system according to claim 8 , wherein the number percentage of basic amino acid residues in the basic patch is 30 or more.

10 . The expression system according to claim 1 , wherein the expression system further comprises a transduction enhancer.

11 . The expression system according to claim 10 , wherein the transduction enhancer is a DNA transfection reagent.

12 . A transcription modulator comprising:

(i) a transcription modulator domain that binds to a transcription modulator responsive element;

(ii) an expression modulatory domain fused to the transcription modulator domain; and

(iii) a distributed protein transduction domain.

13 - 17 . (canceled)

18 . A nucleic acid encoding a transcription modulator comprising:

(i) a transcription modulator domain that binds to a transcription modulator responsive element;

(ii) an expression modulatory domain fused to the transcription modulator domain; and

(iii) a distributed protein transduction domain.

19 - 23 . (canceled)

24 . A method of inducing expression of a coding sequence in a host cell, the method comprising:

(a) providing a host cell comprising:

(i) an expression cassette comprising: a transcription modulator responsive element, a promoter and the coding sequence; and

(ii) a transcription modulator comprising: a transcription modulator domain that binds to the transcription modulator responsive element in an expression mediator mediated manner, an expression modulatory domain operably linked to the transcription modulator domain, and a distributed protein transduction domain; and

(b) maintaining the host cell under conditions sufficient to induce expression of the coding sequence.

25 . The method according to claim 24 , wherein the method comprises changing the concentration in the host cell of an expression mediator that mediates binding of the transcription modulator to the transcription modulator responsive element in a manner sufficient to express the coding sequence.

26 . The method according to claim 24 , wherein the transcription modulator responsive element is a Tet responsive element and the transcription modulator is a Tet regulatory domain.

27 - 29 . (canceled)

30 . The method according to claim 25 , wherein the expression mediator is selected from the group consisting of tetracycline and doxycycline.

31 . The method according to claim 24 , wherein the distributed protein transduction domain comprises a basic patch made up 3 or more non-sequential basic amino acid residues.

32 . The method according to claim 31 , wherein the number percentage of basic amino acid residues in the basic patch is 30 or more.

33 . The method according to claim 24 , wherein the method further comprises contacting the host cell with a transduction enhancer.

33 - 46 . (canceled)

Assignments (2)
CHANGE OF NAME Recorded Aug 4, 2016
From: CLONTECH LABORATORIES, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 039584/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2015
From: BISGROVE, DWAYNE; SAGAWA, HIROAKI
To: CLONTECH LABORATORIES, INC.
Reel/Frame 036499/0051 →